Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Notes Payables (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Notes Payables readings, the most recent being $1.6 million for Q3 2025.

  • On a quarterly basis, Notes Payables fell 83.95% to $1.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.6 million, a 83.95% decrease, with the full-year FY2024 number at $26255.0, down 99.22% from a year prior.
  • Notes Payables hit $1.6 million in Q3 2025 for SBC Medical Group Holdings, down from $3.3 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $10.2 million in Q3 2024 to a low of $26255.0 in Q4 2024.
  • Median Notes Payables over the past 3 years was $2.7 million (2024), compared with a mean of $3.2 million.
  • Biggest five-year swings in Notes Payables: plummeted 99.22% in 2024 and later grew 21.19% in 2025.
  • SBC Medical Group Holdings' Notes Payables stood at $3.4 million in 2023, then plummeted by 99.22% to $26255.0 in 2024, then soared by 6136.41% to $1.6 million in 2025.
  • The last three reported values for Notes Payables were $1.6 million (Q3 2025), $3.3 million (Q2 2025), and $1.4 million (Q1 2025) per Business Quant data.